Amicus Therapeutics Announces Third Quarter 2018 Financial Results and Corporate Updates

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to Amicus Therapeutics Announces Third Quarter 2018 Financial Results and Corporate Updates

Amicus Therapeutics (FOLD) Misses Q3 EPS by 56c, Revenues Miss; Offers FY18 Revenue Outlook Below Consensus

November 5, 2018 7:05 AM EST

Amicus Therapeutics (NASDAQ: FOLD) reported Q3 EPS of ($0.84), $0.56 worse than the analyst estimate of ($0.28). Revenue for the quarter came in at $20.6 million versus the consensus estimate of $23.57 million.

John F. Crowley, Chairman and Chief Executive Officer of Amicus Therapeutics, Inc. stated, The third... More